Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Cytek Biosciences, Inc. | StockGist | StockGist

Companies
CTKB
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings CTKBSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Cytek Biosciences, Inc.

Filed Nov 17, 2025

Accepted Nov 16, 2025, 7:00 PM ET

CIK 0001831915

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

6,780,847

Reporting Person

Cytek Biosciences, Inc.

Person Type

IA

CUSIP: 23285D109

Key Facts

Shares Owned

6,780,847

Recent Filings

Cytek Biosciences, Inc.1 months ago

Cytek Biosciences, Inc.1 months ago

Cytek Biosciences, Inc.2 months ago

Cytek Biosciences, Inc.4 months ago

Cytek Biosciences, Inc.5 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice